IRIS
TISONE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 81.784
AS - Asia 11.116
EU - Europa 7.446
SA - Sud America 1.530
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 17
Totale 102.056
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 81.535
SG - Singapore 5.542
CN - Cina 2.176
RU - Federazione Russa 1.275
BR - Brasile 1.257
HK - Hong Kong 1.255
UA - Ucraina 1.073
DE - Germania 1.048
IT - Italia 899
IE - Irlanda 815
VN - Vietnam 814
FI - Finlandia 661
GB - Regno Unito 454
SE - Svezia 362
FR - Francia 333
KR - Corea 294
JP - Giappone 287
IN - India 196
CA - Canada 133
NL - Olanda 119
AR - Argentina 107
PL - Polonia 95
BD - Bangladesh 80
TR - Turchia 76
AT - Austria 75
ID - Indonesia 71
MX - Messico 69
ES - Italia 58
IQ - Iraq 57
ZA - Sudafrica 47
EC - Ecuador 44
BE - Belgio 35
CL - Cile 29
CZ - Repubblica Ceca 29
CO - Colombia 28
SA - Arabia Saudita 23
EG - Egitto 22
PK - Pakistan 20
PY - Paraguay 20
UZ - Uzbekistan 20
CH - Svizzera 18
AU - Australia 16
IL - Israele 15
PH - Filippine 15
AE - Emirati Arabi Uniti 14
AZ - Azerbaigian 14
JO - Giordania 14
KE - Kenya 14
RO - Romania 14
TH - Thailandia 14
VE - Venezuela 14
EU - Europa 13
MA - Marocco 13
TN - Tunisia 13
GR - Grecia 12
KG - Kirghizistan 12
MY - Malesia 12
UY - Uruguay 12
DZ - Algeria 11
IR - Iran 11
KZ - Kazakistan 11
PE - Perù 11
LT - Lituania 10
NP - Nepal 10
DO - Repubblica Dominicana 9
MD - Moldavia 9
JM - Giamaica 7
OM - Oman 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
LB - Libano 6
NO - Norvegia 6
BG - Bulgaria 5
HN - Honduras 5
NG - Nigeria 5
SN - Senegal 5
AL - Albania 4
AM - Armenia 4
CR - Costa Rica 4
HU - Ungheria 4
KH - Cambogia 4
KW - Kuwait 4
LV - Lettonia 4
MN - Mongolia 4
PS - Palestinian Territory 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
TM - Turkmenistan 4
TW - Taiwan 4
A1 - Anonimo 3
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
DK - Danimarca 3
DM - Dominica 3
HR - Croazia 3
LK - Sri Lanka 3
MK - Macedonia 3
MM - Myanmar 3
NI - Nicaragua 3
PA - Panama 3
Totale 102.008
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.646
Wilmington 21.024
Houston 18.720
Singapore 2.737
Fairfield 2.214
Ann Arbor 1.942
Ashburn 1.461
Hong Kong 1.233
Chandler 1.162
San Jose 1.145
Jacksonville 967
Seattle 951
Cambridge 824
Beijing 820
Dublin 801
New York 757
Medford 599
Santa Clara 443
Helsinki 409
The Dalles 391
Dearborn 330
Los Angeles 314
Rome 306
Zhengzhou 283
Lawrence 281
Ho Chi Minh City 255
Council Bluffs 253
Tokyo 231
Moscow 220
Buffalo 194
Hanoi 181
Mülheim 172
San Diego 146
São Paulo 139
Lauterbourg 126
Orem 102
Menlo Park 95
Dallas 94
Elk Grove Village 91
Milan 90
Hangzhou 87
Chicago 84
Munich 75
London 69
Frankfurt am Main 65
Shanghai 65
Chennai 63
Jersey City 58
Nuremberg 58
Montreal 54
San Mateo 54
Creede 51
North Bergen 50
Redwood City 50
Atlanta 49
University Park 49
Warsaw 49
Guangzhou 47
Palo Alto 46
Manchester 45
Phoenix 45
Mountain View 44
Amsterdam 43
Rio de Janeiro 43
Jakarta 41
Nanjing 41
Boardman 39
Denver 39
Falls Church 39
Saint Petersburg 39
Verona 39
Johannesburg 38
Norwalk 38
Stockholm 37
Redondo Beach 36
Poplar 34
San Francisco 34
Brooklyn 33
Hefei 33
Vienna 33
Columbus 30
Kraków 30
Seoul 30
Da Nang 29
Toronto 29
Lappeenranta 28
Brussels 27
Engelhard 27
Belo Horizonte 26
Haiphong 26
Salt Lake City 25
Kunming 24
Mexico City 24
Mumbai 23
Turku 23
Brasília 22
Curitiba 21
Ankara 20
Baghdad 18
Quito 18
Totale 87.585
Salva come PNG Salva come JPEG
Nome #
Hepatitis C reinfection after liver transplantation in relation to virus genotype 607
Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression 577
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 553
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 522
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 519
Recurrence of insulin resistant metabolic syndrome following liver transplantation 506
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 505
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 505
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 500
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 497
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 497
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 496
Graft failure due to hemolytic uremic syndrome recurrence 493
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 493
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 491
Operational tolerance in clinical liver transplantation: emerging developments. 487
Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. 485
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 485
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft 484
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft. 477
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 477
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 475
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 474
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 473
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 470
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 468
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 467
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 466
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 465
Infectious complications in renal transplant recipients 464
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 463
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 461
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 460
Conversion to rapamycin immunosuppression for malignancy after kidney transplantation 460
Marginal donors in liver transplantation. 460
Use of mycophenolate mofetil in liver transplantation: a literature review. 459
Leptin attenuates ischemia-reperfusion injury in the rat liver. 457
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 456
Is nephrectomy indicated in uremic patients with ADPKD waiting for transplant? 456
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 453
596 453
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 452
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 451
Clinical and neurophysiological evidence of polyneuropathy in liver transplant candidates: preliminary report. 450
Management of spermatic cord liposarcoma in renal transplant recipients: case report 446
10-28 year follow-up in 23 patients with kideny traansplantation: immunosuppressive therapy, survival and complications 446
Liver abscess caused by foreign body ingestion 446
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 445
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. 444
Flow cytometric analysis of antidonor-specific antibodies in liver transplant. 443
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: With or without steroids? 443
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 442
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 441
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 441
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 441
Multiparameter immune profiling of operational tolerance in liver transplantation. 441
Quality of life and long-term follow-up after kidney transplantation: a 30-year clinical study. 441
Phase I clinical trial with the AMC-bioartificial liver. 440
Graft failure due to hemolytic uremic syndrome recurrence 439
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 439
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 438
Ureteral obstruction in 140 renal transplant patients: preventions and treatment 438
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 437
Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. 436
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 436
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 436
Immunosuppression-Free Liver Transplantation 435
Sequential changes in serum and biliary bile acids after liver transplantation 433
Reduced acute rejection and side effects with neoral in liver transplantation. 433
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 432
Liver transplantation for end-stage liver disease related to viral hepatitis 431
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 431
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 429
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 428
Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. 428
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 428
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C 427
Surgical versus percutaneous technique for veno-venous bypass during orthotopic liver transplantation: a prospective randomized study. 427
Clinical Significance of de novo production of HLA of donor-specific antibodies in kidney transplantation. 427
Split-liver transplantation with pediatric donors: a multicenter experience. 427
Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. 427
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 426
Spontaneous resolution of severe acute rejection in liver transplantation. 425
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 425
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. 425
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 425
[An unusual case of ureteral obstruction after kidney transplantation]. 424
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 424
Average results and follow-up in 11 over-60 years of age kidney transplanted patients 423
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation 422
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 420
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. 420
2.0 J Ti:sapphire laser oscillator. 420
Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome. 420
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 420
Metabolic findings after liver transplantation within a randomised trial with or without steroids 419
Liver transplantation for the treatment of nodular regenerative hyperplasia 419
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 419
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report 418
Totale 45.582
Salva come PNG Salva come JPEG
Categoria #
all - tutte 240.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 240.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021967 0 0 0 0 0 0 0 0 0 304 492 171
2021/20222.815 104 300 92 159 78 324 133 118 270 311 123 803
2022/20233.515 373 285 80 362 272 799 322 323 295 23 291 90
2023/20241.299 145 41 187 25 137 306 52 40 31 65 23 247
2024/20258.341 254 1.658 822 477 138 572 593 305 753 713 1.167 889
2025/202612.562 1.032 692 1.339 1.344 1.231 829 1.768 1.799 1.443 1.085 0 0
Totale 102.983